IP Library › Granted Patent US 6,991,814
Granted Patent B2
US 6,991,814 · App. 10/319,373 · Granted Jan 31, 2006

Herbal medicaments for the treatment of neurocerebrovascular disorders

Assignee: Council of Scientific and Industrial Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,991,814
App. No.
10/319,373
Granted
Jan 31, 2006
Kind
B2
Abstract

The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of Curcuma species of Zingiberaceae family, useful for the treatment of neurocerebrovascular disorders, said composition comprising fraction A consisting of ar-turmerone of formula 1, and turmerone of formula 2, and/or along with fraction B consisting of curcumene and zingiberine, and/or fraction C consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol, curcumenone, and curlone, and/or pharmaceutically acceptable additives and a method of treating neurocerebrovascular disorders in animals including humans using said composition by administering therapeutically effective amount of lipid soluble extract.

Claims (24)

1. A method for obtaining a lipid soluble extract from rhizomes and leaves of Curcuma species of the Zingiberaceae family and fractions of the lipid soluble extract, said method comprising the steps of:

a) powdering the rhizomes and leaves of the Curcuma species to obtain a powder;

b) extracting the powder with a polar organic solvent selected from the group consisting of alcohol and acetone under continuous stirring or sonication for about 24 hours at room temperature;

c) repeating step b) two to five times.

d) removing the polar organic solvent by distillation under reduced pressure and below 45° C. to obtain a concentrate;

e) triturating the concentrate with a non-polar solvent selected from the group consisting of light petroleum and toluene;

f) removing the non-polar solvent by distillation under reduced pressure and below 45° C. to obtain the lipid soluble extract;

g) fractionating the lipid soluble extract using silica gel column chromatography using n-hexane, n-hexane:ethyl acetate mixture in a ratio of 95:5, and ethyl acetate as eluents which are used successively to obtain fraction A, fraction B, and fraction C, and

j) fractionating each of fractions A, fraction B, and C further using HPLC or GLC to obtain the constituents of fractions A, B and C wherein the constituents of fraction A are selected from the group consisting of ar-turmerone of formula 1 and turmerone of formula 2; constituents of fraction B are selected from the group consisting of curcumene and zingiberine and constituents of fraction C are selected from the group consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol and curlone.

2. The method as claimed in claim 1 , wherein fraction A constitutes about 75% by weight of the lipid soluble extract.

3. The method as claimed in claim 1 , wherein ar-tumerone constitutes 95% of the fraction A.

4. The method as claimed in claim 1 , wherein the pressure in steps d) and f) ranges between 7 and 11 mmHg.

5. A method for obtaining a lipid soluble extract from rhizomes and leaves of Curcuma species of the Zingiberaceae family, said method comprising the steps of:

a) powdering the rhizomes and leaves of the Curcuma species to obtain a powder;

b) extracting the powder with a polar organic solvent selected from the group consisting of acetone and alcohol under continuous stirring or sonication for about 24 hours at room temperature;

c) repeating step b) two to five times,

d) removing the polar organic solvent by distillation under reduced pressure and below 45° C. to obtain a concentrate;

e) triturating the concentrate with a non-polar solvent selected from the group consisting of light potroleum and toluene; and

f) removing the non-polar solvent by distillation under reduced pressure and below 45° C. to obtain the lipid soluble extract.

6. A method for fractionating the lipid soluble extract prepared by the method of claim 5 , comprising the steps of

a) fractionating the lipid soluble extract using silica gel column chromatography using n-hexane, n-hexane:ethyl acetate mixture in a ratio of 95:5, and ethyl acetate as eluents which are used successively to obtain fraction A, fraction B, and fraction C, and

b) fractionating each of fractions A, fraction B, and C further using HPLC or GLC to obtain the constituents of fractions A, B and C wherein the constituents of fraction A are selected from the group consisting of ar-turmerone of formula 1 and turmerone of formula 2; constituents of fraction B are selected from the group consisting of curcumene and zingiberine and constituents of fraction C are selected from the group consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol and curlone.

7. The method as claimed in claim 6 , wherein fraction A constitutes about 75% by weight of the lipid soluble extract.

8. The method as claimed in claim 6 , wherein ar-tumerone constitutes 95% of the fraction A.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2003
From: RAY, MADHUR; PAL, RAGHWENDRA; SINGH, SATYAWAN; KHANNA, NANDOO MAL
To: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
Reel/Frame 014013/0544 →
Continuity (2)
Provisional Application 6034016500 · Dec 14, 2001
Related Publication 20040033277A1 · Feb 19, 2004